Craft

Bausch Health

Stock Price

$7.4

2024-05-07

Market Capitalization

$2.7 B

2024-05-07

Revenue

$8.8 B

FY, 2023

Bausch Health Summary

Company Summary

Overview
Bausch Health (also known as Bausch Health Companies, formerly known as Valeant Pharmaceuticals) is a company that develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. It operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb/International segment offers vision care, surgical, consumer, and ophthalmology Rx products; Solta products, branded and generic pharmaceutical products, OTC products, medical devices, and Bausch + Lomb products. The Salix segment provides gastroenterology products. The Ortho Dermatologics segment offers dermatological products and Solta medical aesthetic devices. The Diversified Products segment provides pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products.
Type
Public
Status
Active
Founded
1959
HQ
Laval, CA | view all locations
Website
https://www.bauschhealth.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Louis Yu
  • Paul Herendeen

    Paul Herendeen, Executive Vice President and Chief Financial Officer

    • Tage Ramakrishna

      Tage Ramakrishna, Chief Medical Officer, President, R&D

    • Joseph Gordon

      Joseph Gordon, President & Co-Head, Bausch + Lomb/International

    Operating MetricsView all

    Projects in R&D Pipeline

    225
    87.5%

    FY, 2019

    Manufacturing Facilities

    37
    2.6%

    FY, 2019

    Product Brands

    101
    12.2%

    FY, 2019

    LocationsView all

    47 locations detected

    • Laval, QC HQ

      Canada

      2150 Boulevard Saint-Elzéar O

    • Clearwater, FL

      United States

      21 N Park Pl Blvd

    • Greenville, SC

      United States

      8507 Pelham Rd

    • Irvine, CA

      United States

      15272 Alton Pkwy #200

    • Irvine, CA

      United States

      50 Technology Dr

    • Lynchburg, VA

      United States

      1501 Graves Mill Rd

    and 41 others

    Bausch Health Financials

    Summary Financials

    Revenue (Q1, 2024)
    $2.2B
    Net income (Q1, 2024)
    ($77.0M)
    Cash (Q1, 2024)
    $733.0M
    EBIT (Q1, 2024)
    $281.0M
    Enterprise value
    $24.1B

    Footer menu